Dropout rates and factors associated with adherence to opioid agonist treatment among adults with opioid use disorder at Sekou Toure Regional Referral Hospital, Mwanza, Tanzania. [PDF]
Tuli TH +6 more
europepmc +1 more source
ABSTRACT This study evaluated the pharmacokinetics of an extended‐release buprenorphine formulation (Ethiqa XR) in dogs and explored potential sex differences. Twelve healthy intact beagles (6 males and 6 females) received a single subcutaneous injection of Ethiqa XR (0.2 mg/kg).
Kornelia Tiffinger +5 more
wiley +1 more source
Persisting high rates of mental health disorders in patients in opioid agonist treatment-Results from a 6-year longitudinal study. [PDF]
Soyka M +3 more
europepmc +1 more source
Characterization of the Pharmacokinetics and Physiological Effects of Tapentadol in Horses
ABSTRACT Tapentadol is a dual mechanism analgesic utilizing both μ‐opioid receptor (MOR) agonism and norepinephrine reuptake inhibition (NRI). This study evaluated the pharmacokinetics and pharmacodynamics of tapentadol as a potential analgesic with the goal of treating pain in horses.
Annabella D. Lynch +4 more
wiley +1 more source
A feasibility study of a co-designed intervention to manage benzodiazepine dependence and high-risk use in those receiving opioid agonist treatment. [PDF]
Matheson C +9 more
europepmc +1 more source
ABSTRACT The misuse and abuse of veterinary anesthetic and analgesic agents pose significant public health risks, particularly with the growing presence of ultrapotent opioids and other anesthetics in the illicit drug trade. In response, there is increasing emphasis on incorporating medication safety training into veterinary curricula.
Margene Anderson +2 more
wiley +1 more source
Treatment satisfaction among patients in opioid agonist treatment in Norway: A multicenter cohort study. [PDF]
Nesse L, Clausen T.
europepmc +1 more source
Abstract This paper analyzes two disparate experiences of buprenorphine, a medication for opioid addiction, in California. Within the context of the U.S. War on Drugs and after decades of criminalization, buprenorphine represents a shift toward outpatient medical treatment of opioid addiction, but it has been unequally distributed and experienced ...
Textor Lauren
wiley +1 more source
National consensus statement on opioid agonist treatment in custodial settings. [PDF]
Chan J +7 more
europepmc +1 more source
Exploring metacognitive function in patients with opioid use disorder: A pilot study
Abstract Objectives Despite recognised cognitive deficits related to substance use, as well as high mortality and treatment attrition rates, metacognition has never been studied in patients with opioid use disorder (OUD) undergoing opioid maintenance treatment (OMT).
John Hanson Högberg +3 more
wiley +1 more source

